Rights Issue - TO2 & TO3

At the extraordinary general meeting on October 16, 2023, a decision was made to issue a maximum of 145,848,299 units, each containing seven (7) shares, seven (7) warrants of series TO2, and seven (7) warrants of series TO3, with preferential rights for existing shareholders.

Each warrant of series TO2 entitles the holder to subscribe for one (1) share at a subscription price equal to 70 percent of the volume-weighted average price of the Company’s shares on the Nasdaq First North Growth Market from December 27, 2023, to January 10, 2024, but not less than the share’s par value and not more than 0.05 SEK. New shares can be subscribed for during the period from January 12, 2024, to January 26, 2024.

Each warrant of series TO3 entitles the holder to subscribe for one (1) share at a subscription price equal to 70 percent of the volume-weighted average price of the Company’s shares on the Nasdaq First North Growth Market from September 17, 2024, to September 30, 2024, but not less than the share’s par value and not more than 0.06 SEK. New shares can be subscribed for during the period from October 2, 2024, to October 16, 2024.

Outcome of the Rights Issue and TO2:

The rights issue was subscribed to approximately 88.6 percent and the Company was provided approximately 36.2 million SEK before issue costs.

The warrants of series 2 (TO2) were subscribed to approximately 72.6 percent and the Company was provided 15.4 million SEK before issue costs.

Download the EU Growth Prospectus here.